Isomorphic Labs secures $5 billion in second major round
Isomorphic Labs, Alphabet’s artificial intelligence drug-discovery company, has raised $5 billion in a financing round led jointly by Greenoaks and Sequoia Capital. Andreessen Horowitz participated as a new investor, while Alphabet and all existing backers also took part. The company raised $2.1 billion in May 2026, making this its second billion-dollar round within six months.